Published in Women's Health Weekly, December 3rd, 2009
"We sought to determine whether concomitant DCIS affects outcomes in patients with invasive disase. A nested cohort study was performed of 1, 709 invasive breast cancer patients. Climcopathlogic data, along with survivakl and recurrence data, were collected prospectively. Resuts. Concomtant DCIS was noted in 434 (25.4%) patients. Median follow-up was 59 months. On univariate analysis, the presence of DCIS was associated with a trend toward improved 5-year diases-free survival (93.6% vs 90.5%; P -...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly